‘Upper echelons of administration’ recognize need for growth in kidney disease treatments
An Executive Order signed by President Trump aims to increase research, incentives, and treatment access for kidney disease patients and could 'fundamentally transform kidney therapeutics,' says president of the American Society of Nephrology.
